Metalloproteinases and their Tissue Inhibitors in Multiple Sclerosis
- 30 June 1999
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 12 (4) , 297-303
- https://doi.org/10.1006/jaut.1999.0285
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric AcetateJournal of Biological Chemistry, 1995
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994
- Processing of tumour necrosis factor-α precursor by metalloproteinasesNature, 1994
- Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic ProteinBiochemical and Biophysical Research Communications, 1993
- The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseasesTrends in Biotechnology, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- MS: a localized immune disease of the central nervous systemImmunology Today, 1989
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983